http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101183520-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2300-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-5428
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23J3-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-012
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23J1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23J1-09
filingDate 2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101183520-B1
titleOfInvention Method for preparing egg yolk phosphorylated protein
abstract The present invention relates to a method for preparing phosphorylated protein from egg yolk, comprising the steps of diluting egg yolk in water; Centrifuging the diluted egg yolk and obtaining a primary precipitate; Diluting the obtained precipitate with water to homogenize it, and then centrifuging again to obtain a secondary precipitate; Mixing the obtained secondary precipitate with ethanol and then centrifuging to remove phospholipids; Dissolving the precipitate from which the phospholipid is removed in a salt solution, followed by centrifugation to obtain a supernatant; and removing the salt of the obtained supernatant, and a method for producing phosphorylated protein from egg yolk. It is about. The yolk phosphorylated protein prepared by the above method is environmentally friendly and can overcome the toxic hazards caused by residual organic solvents by fractionating the phosphorylated protein of yolk without using it in toxic organic solvents. It can be used as a food and cosmetic natural material with various functions such as antioxidant, antibacterial, anti-osteoporosis, antihypertensive, anticancer, whitening.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220133435-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102511889-B1
priorityDate 2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481998
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399320
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID539235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100873151
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30428
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81650
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1460
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8839
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD1MEJ0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID112530988
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8801
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8624673

Total number of triples: 41.